Matches in SemOpenAlex for { <https://semopenalex.org/work/W2416404329> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2416404329 endingPage "151" @default.
- W2416404329 startingPage "147" @default.
- W2416404329 abstract "The prediction of the consequences of disease is important to determine the therapy approaches and prevention of the chronical state in patients infected with hepatitis B virus (HBV). In recent years various studies are carried on to investigate the effect of IL-28B gene polymorphisms on the clinical course or therapy response in patients with chronic hepatitis B infection. The aim of the study was to evaluate the influence of IL-28B rs12979860 polymorphisms on the natural course of HBV infection. The study was designed prospectively, and the subjects were randomly selected among patients admitted to infectious disease outpatient clinics of Kocatepe University Medical School Hospital and Yunus Emre State Hospital located at provinces in Central Anatolia, Turkey. A total of 99 cases were included in the study and evaluated into three groups, namely, chronic hepatitis B patients (group 1, n= 43); inactive HBV carriers (group 2, n= 34) and subjects with acquired immunity after native infection (group 3, n= 22). There were no significant differences regarding the age and gender distribution between the groups (p> 0.05). All subjects were investigated for the IL-28B promoter single nucleotide polymorphism rs12979860 at position 3176 C/T, by real-time polymerase chain reaction (RT-PCR). Evaluation of the range of IL-28B rs12979860 C/T polymorphisms observed in the study groups showed that, the frequency of CC, CT and TT allels were as follows; 34.9%, 48.8% and 16.3 % in group 1; 47.1%, 35.3% and 17.6% in group 2; 63.6%, 27.7% and 13.6% in group 3, respectively. No significant differences were observed between the groups in terms of C/T allel distriubution (p> 0.05). However, in spite of statistical insignificance, the rate of CC allel in IL-28B rs12979860 gene was the highest in immune subjects (63.6%), while it was the lowest in chronic hepatitis B patients (34.9%). According to our data, IL-28B rs12979860 gene polymorphisms were not effective on the clinical course of HBV infection. In conclusion, further studies with large numbers of patients are needed to support these data." @default.
- W2416404329 created "2016-06-24" @default.
- W2416404329 creator A5005541688 @default.
- W2416404329 creator A5015632661 @default.
- W2416404329 creator A5043622549 @default.
- W2416404329 creator A5046961182 @default.
- W2416404329 creator A5047256102 @default.
- W2416404329 creator A5078355487 @default.
- W2416404329 date "2016-01-07" @default.
- W2416404329 modified "2023-10-18" @default.
- W2416404329 title "Effect of IL-28B Polymorphisms on the Natural Course of HBV Infection" @default.
- W2416404329 doi "https://doi.org/10.5578/mb.10741" @default.
- W2416404329 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27058339" @default.
- W2416404329 hasPublicationYear "2016" @default.
- W2416404329 type Work @default.
- W2416404329 sameAs 2416404329 @default.
- W2416404329 citedByCount "0" @default.
- W2416404329 crossrefType "journal-article" @default.
- W2416404329 hasAuthorship W2416404329A5005541688 @default.
- W2416404329 hasAuthorship W2416404329A5015632661 @default.
- W2416404329 hasAuthorship W2416404329A5043622549 @default.
- W2416404329 hasAuthorship W2416404329A5046961182 @default.
- W2416404329 hasAuthorship W2416404329A5047256102 @default.
- W2416404329 hasAuthorship W2416404329A5078355487 @default.
- W2416404329 hasConcept C104317684 @default.
- W2416404329 hasConcept C126322002 @default.
- W2416404329 hasConcept C203014093 @default.
- W2416404329 hasConcept C2522874641 @default.
- W2416404329 hasConcept C2777382497 @default.
- W2416404329 hasConcept C2780040827 @default.
- W2416404329 hasConcept C2780593183 @default.
- W2416404329 hasConcept C2781399841 @default.
- W2416404329 hasConcept C3020491458 @default.
- W2416404329 hasConcept C49105822 @default.
- W2416404329 hasConcept C54355233 @default.
- W2416404329 hasConcept C71924100 @default.
- W2416404329 hasConcept C86803240 @default.
- W2416404329 hasConcept C90924648 @default.
- W2416404329 hasConceptScore W2416404329C104317684 @default.
- W2416404329 hasConceptScore W2416404329C126322002 @default.
- W2416404329 hasConceptScore W2416404329C203014093 @default.
- W2416404329 hasConceptScore W2416404329C2522874641 @default.
- W2416404329 hasConceptScore W2416404329C2777382497 @default.
- W2416404329 hasConceptScore W2416404329C2780040827 @default.
- W2416404329 hasConceptScore W2416404329C2780593183 @default.
- W2416404329 hasConceptScore W2416404329C2781399841 @default.
- W2416404329 hasConceptScore W2416404329C3020491458 @default.
- W2416404329 hasConceptScore W2416404329C49105822 @default.
- W2416404329 hasConceptScore W2416404329C54355233 @default.
- W2416404329 hasConceptScore W2416404329C71924100 @default.
- W2416404329 hasConceptScore W2416404329C86803240 @default.
- W2416404329 hasConceptScore W2416404329C90924648 @default.
- W2416404329 hasIssue "1" @default.
- W2416404329 hasLocation W24164043291 @default.
- W2416404329 hasLocation W24164043292 @default.
- W2416404329 hasOpenAccess W2416404329 @default.
- W2416404329 hasPrimaryLocation W24164043291 @default.
- W2416404329 hasRelatedWork W1988242030 @default.
- W2416404329 hasRelatedWork W2033765392 @default.
- W2416404329 hasRelatedWork W2046653726 @default.
- W2416404329 hasRelatedWork W2340964019 @default.
- W2416404329 hasRelatedWork W2347909516 @default.
- W2416404329 hasRelatedWork W2362956591 @default.
- W2416404329 hasRelatedWork W2377909279 @default.
- W2416404329 hasRelatedWork W2616317258 @default.
- W2416404329 hasRelatedWork W4206959277 @default.
- W2416404329 hasRelatedWork W4210380841 @default.
- W2416404329 hasVolume "50" @default.
- W2416404329 isParatext "false" @default.
- W2416404329 isRetracted "false" @default.
- W2416404329 magId "2416404329" @default.
- W2416404329 workType "article" @default.